Department of Chemistry , University of Louisville , Louisville , Kentucky 40292 , United States.
Department of Medicine, James Graham Brown Cancer Center , University of Louisville , Louisville , Kentucky 40202 , United States.
Biochemistry. 2019 Feb 26;58(8):1048-1060. doi: 10.1021/acs.biochem.8b00943. Epub 2019 Feb 11.
Thrombin, derived from zymogen prothrombin (ProT), is a serine protease involved in procoagulation, anticoagulation, and platelet activation. Thrombin's actions are regulated through anion-binding exosites I and II (ABE I and ABE II) that undergo maturation during activation. Mature ABEs can utilize exosite-based communication to fulfill thrombin functions. However, the conformational basis behind such long-range communication and the resultant ligand binding affinities are not well understood. Protease activated receptors (PARs), involved in platelet activation and aggregation, are known to target thrombin ABE I. Unexpectedly, PAR3 (44-56) can already bind to pro-ABE I of ProT. Nuclear magnetic resonance (NMR) ligand-enzyme titrations were used to characterize how individual PAR1 (49-62) residues interact with pro-ABE I and mature ABE I. 1D proton line broadening studies demonstrated that binding affinities for native PAR1P (49-62, P54) and for the weak binding variant PAR1G (49-62, P54G) increased as ProT was converted to mature thrombin. H,N-HSQC titrations revealed that PAR1G residues K51, E53, F55, D58, and E60 exhibited less affinity to pro-ABE I than comparable residues in PAR3G (44-56, P51G). Individual PAR1G residues then displayed tighter binding upon exosite maturation. Long-range communication between thrombin exosites was examined by saturating ABE II with phosphorylated GpIbα (269-282, 3Yp) and monitoring the binding of PAR1 and PAR3 peptides to ABE I. Individual PAR residues exhibited increased affinities in this dual-ligand environment supporting the presence of interexosite allostery. Exosite maturation and beneficial long-range allostery are proposed to help stabilize an ABE I conformation that can effectively bind PAR ligands.
凝血酶来源于酶原凝血酶原(ProT),是一种参与促凝、抗凝和血小板激活的丝氨酸蛋白酶。凝血酶的作用通过阴离子结合外位 I 和 II(ABE I 和 ABE II)调节,这些外位在激活过程中成熟。成熟的 ABE 可以利用基于外位的通讯来发挥凝血酶的功能。然而,这种远程通讯背后的构象基础以及由此产生的配体结合亲和力尚不清楚。参与血小板激活和聚集的蛋白酶激活受体(PARs)已知靶向凝血酶 ABE I。出乎意料的是,PAR3(44-56)已经可以结合 ProT 的前 ABE I。使用核磁共振(NMR)配体-酶滴定法来表征单个 PAR1(49-62)残基如何与前 ABE I 和成熟 ABE I 相互作用。1D 质子线展宽研究表明,天然 PAR1P(49-62,P54)和弱结合变体 PAR1G(49-62,P54G)的结合亲和力随着 ProT 转化为成熟的凝血酶而增加。H,N-HSQC 滴定显示,PAR1G 残基 K51、E53、F55、D58 和 E60 与 PAR3G(44-56,P51G)中的可比残基相比,对前 ABE I 的亲和力较低。然后,单个 PAR1G 残基在外位成熟后显示出更紧密的结合。通过用磷酸化 GpIbα(269-282,3Yp)饱和 ABE II 并监测 PAR1 和 PAR3 肽与 ABE I 的结合,研究了凝血酶外位之间的长程通讯。在这种双重配体环境中,单个 PAR 残基表现出更高的亲和力,支持存在外位变构。外位成熟和有益的远程变构被认为有助于稳定能够有效结合 PAR 配体的 ABE I 构象。